Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02913495 · ClinicalTrials.gov registry record · Phase 4
Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth
A Phase 4 study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Phase 4
- Development phase
- 210
- Enrollment target
NCT02913495: Completed Phase 4 study, sponsored by Thomas Jefferson University.
NCT02913495 is a Phase 4 study that has completed, run by Thomas Jefferson University. The registered enrollment target is 210 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02913495, a Phase 4 study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 210 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the two suggested therapies for prevention of recurrent preterm birth (PTB) in women with a prior spontaneous preterm birth, vaginal and intramuscular progesterone to determine whether vaginal progesterone is superior to intramuscular progesterone in the prevention of recurrent preterm birth.
Primary Outcome
Incidence of gestational age of delivery less than 37 weeks
Interventions
- DRUG Vaginal Progesterone
- DRUG Intramuscular Progesterone (17 alpha hydroxprogesterone caproate)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2016-09 |
| Est. Completion | 2021-09 |
| Phase | Phase 4 |
What the finished NCT02913495 record still lists
NCT02913495 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 2 interventions - of which Vaginal Progesterone is the first listed.
NCT02913495 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02913495 about?
NCT02913495 is a clinical study titled "Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth". The purpose of this study is to evaluate the two suggested therapies for prevention of recurrent preterm birth (PTB) in women with a prior spontaneous preterm birth, vaginal and intramuscular progesterone to determine whether vaginal progesterone is superior to intramuscular progesterone in the prev...
What is the current status of trial NCT02913495?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 210 participants. The study started on 2016-09. Estimated completion is 2021-09.
What interventions are being tested in trial NCT02913495?
The interventions under investigation include: Vaginal Progesterone (DRUG), Intramuscular Progesterone (17 alpha hydroxprogesterone caproate) (DRUG).
Who is sponsoring clinical trial NCT02913495?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02913495's enrollment target sits among peer trials
210 398th of 2000 higher than 1,602 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia